SCHEMBL7490691

SCHEMBL7490691

CC(C)C[C@H](NC(=O)c1ccc(Nc2nc(-c3ccncc3)cs2)cc1)C(=O)N(C)C#N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSB P07858 5/20 0.51
CTSL P07711 2/20 0.46
CTSS P25774 2/20 0.46
CTSK P43235 2/20 0.46
CSNK2A1 P68400 1/20 0.46
NPC1 O15118 6/20 0.46
RAB9A P51151 6/20 0.46
MAPT P10636 5/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
VCP P55072 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
NAMPT P43490 1/20 0.44
MPL P40238 2/20 0.44
TDP1 Q9NUW8 2/20 0.43
ESR1 P03372 1/20 0.43
POLB P06746 1/20 0.43
ALOX5 P09917 1/20 0.43
PARP1 P09874 1/20 0.43
GAA P10253 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7486512 0.97 CTSB (0.50) CTSBCTSLCTSSCTSKCSNK2A1
SCHEMBL7515230 0.88 CTSB (0.52) CTSBCTSLCTSSCTSKNPC1
SCHEMBL6181728 0.85 ALOX5 (0.43) CSNK2A1NPC1RAB9AMAPTMEN1
SCHEMBL7483503 0.85 CTSB (0.50) CTSBCTSLCTSSCTSKNPC1
SCHEMBL6183917 0.85 CTSB (0.58) CTSBCTSLCTSSCTSKCSNK2A1
SCHEMBL7506517 0.85 NPC1 (0.51) CTSBCTSLCTSSCTSKNPC1
SCHEMBL6185994 0.83 CTSB (0.54) CTSBCTSLCTSSCTSKNPC1
SCHEMBL7450318 0.83 CTSB (0.54) CTSBCTSLCTSSCTSKALDH1A1
SCHEMBL7450076 0.83 CTSB (0.54) CTSBCTSLCTSSCTSKNPC1
SCHEMBL6184002 0.82 CTSB (0.60) CTSBCTSLCTSSCTSKCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001068645-A2 N-CYANOMETHYLCARBOXAMIDES AND THEIR USE AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2001-09-20 WO disclosed